Milestone® Pharmaceuticals (NASDAQ:MIST) announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for its New Drug Application (NDA) for CARDAMYST™ ...

Neuren Pharmaceuticals (ASX:NEU) has announced the development of NNZ-2591 as a potential treatment for hypoxic-ischemic encephalopathy, a severe brain injury occurring in newborns due to insufficient ...

Victory Metals (ASX:VTM) has produced gallium in its final mixed rare earth carbonate product from the North Stanmore clay-hosted heavy rare earth and critical mineral project in Western Australia.